ESR1 and neoplasm: Noting that TNBC samples demonstrated a trend in higher percentages of immune cell infiltrates in primary tumours compared to ER+ and HER2‐amplified primary samples, aligning with the prior observations of robust immune infiltrates in this subtype.88, 89, 90